These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24410269)

  • 21. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical formulations--suspensions and solutions.
    Edman P
    J Aerosol Med; 1994; 7(Suppl 1):S3-6. PubMed ID: 10147074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle.
    Wagner DS; Johnson CE; Cichon-Hensley BK; DeLoach SL
    Am J Health Syst Pharm; 2003 Jun; 60(12):1268-70. PubMed ID: 12845924
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration.
    Pedersen BT; Larsen SW; Østergaard J; Larsen C
    Drug Deliv; 2008 Jan; 15(1):23-30. PubMed ID: 18197520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of morphine diffusion from sustained release polymeric suspensions.
    Morales ME; Gallardo Lara V; Calpena AC; Doménech J; Ruiz MA
    J Control Release; 2004 Feb; 95(1):75-81. PubMed ID: 15013234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years.
    Tolia V; Johnston G; Stolle J; Lee C
    Paediatr Drugs; 2004; 6(2):127-31. PubMed ID: 15035653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanosuspensions: a promising drug delivery strategy.
    Patravale VB; Date AA; Kulkarni RM
    J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients.
    Miyazaki S; Takahashi A; Itoh K; Ishitani M; Dairaku M; Togashi M; Mikami R; Attwood D
    Drug Dev Ind Pharm; 2009 Jul; 35(7):780-7. PubMed ID: 19337871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
    Rao MR; Bhingole RC
    Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of nanosuspensions in drug delivery.
    Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D
    J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation strategies for absorption windows.
    Davis SS
    Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
    Leone F; Cavalli R
    Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-release dosage: recent advances and potential in pediatric medicine.
    Flament MP
    Ther Deliv; 2016; 7(4):197-9. PubMed ID: 27010982
    [No Abstract]   [Full Text] [Related]  

  • 37. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
    Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The physical and chemical stability of suspensions of sustained-release diclofenac microspheres.
    Lewis L; Boni RL; Adeyeye CM
    J Microencapsul; 1998; 15(5):555-67. PubMed ID: 9743912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations.
    Malinowski H; Marroum P; Uppoor VR; Gillespie W; Ahn HY; Lockwood P; Henderson J; Baweja R; Hossain M; Fleischer N; Tillman L; Hussain A; Shah V; Dorantes A; Zhu R; Sun H; Kumi K; Machado S; Tammara V; Ong-Chen TE; Mahayni H; Lesko L; Williams R
    Adv Exp Med Biol; 1997; 423():269-88. PubMed ID: 9269503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.